Exploring the therapeutic potential of phytochemicals in Alzheimer's disease: Focus on polyphenols and monoterpenes
I Piccialli, V Tedeschi, L Caputo, S D'Errico… - Frontiers in …, 2022 - frontiersin.org
Alzheimer's disease (AD) is a chronic, complex neurodegenerative disorder mainly
characterized by the irreversible loss of memory and cognitive functions. Different …
characterized by the irreversible loss of memory and cognitive functions. Different …
The blood–brain barrier and its intercellular junctions in age-related brain disorders
L Costea, Á Mészáros, H Bauer, HC Bauer… - International journal of …, 2019 - mdpi.com
With age, our cognitive skills and abilities decline. Maybe starting as an annoyance, this
decline can become a major impediment to normal daily life. Recent research shows that the …
decline can become a major impediment to normal daily life. Recent research shows that the …
Cerebrovascular pathology during the progression of experimental Alzheimer's disease
P Giannoni, M Arango-Lievano, ID Neves… - Neurobiology of …, 2016 - Elsevier
Clinical and experimental evidence point to a possible role of cerebrovascular dysfunction in
Alzheimer's disease (AD). The 5xFAD mouse model of AD expresses human amyloid …
Alzheimer's disease (AD). The 5xFAD mouse model of AD expresses human amyloid …
Association between APOE e4 and white matter hyperintensity volume, but not total brain volume or white matter integrity
Apolipoprotein (APOE) e4 genotype is an accepted risk factor for accelerated cognitive
aging and dementia, though its neurostructural substrates are unclear. The deleterious …
aging and dementia, though its neurostructural substrates are unclear. The deleterious …
Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson's disease
H Chen, H Wan, M Zhang, G Liu, X Wang… - Parkinsonism & Related …, 2021 - Elsevier
Introduction Emerging evidence has suggested that cerebral small vessel disease (CSVD)
may worsen motor function and cognition in Parkinson's disease (PD). However, the effect of …
may worsen motor function and cognition in Parkinson's disease (PD). However, the effect of …
Metrnl regulates cognitive dysfunction and hippocampal BDNF levels in D-galactose-induced aging mice
C Hong, Z Wang, S Zheng, W Hu, S Wang… - Acta Pharmacologica …, 2023 - nature.com
Aging is one of the main risk factors for cognitive dysfunction. During aging process, the
decrease of brain-derived neurotrophic factor (BDNF) and the impairment of astrocyte …
decrease of brain-derived neurotrophic factor (BDNF) and the impairment of astrocyte …
A white matter connection of schizophrenia and Alzheimer's disease
P Kochunov, A Zavaliangos-Petropulu… - Schizophrenia …, 2021 - academic.oup.com
Schizophrenia (SZ) is a severe psychiatric illness associated with an elevated risk for
developing Alzheimer's disease (AD). Both SZ and AD have white matter abnormalities and …
developing Alzheimer's disease (AD). Both SZ and AD have white matter abnormalities and …
Hypertension and age-related cognitive impairment: common risk factors and a role for precision aging
Abstract Purpose of Review Precision Aging® is a novel concept that we have recently
employed to describe how the model of precision medicine can be used to understand and …
employed to describe how the model of precision medicine can be used to understand and …
Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-β and tau pathology
Alzheimer's disease, characterized by brain deposits of amyloid-β plaques and
neurofibrillary tangles, is also linked to neurovascular dysfunction and blood–brain barrier …
neurofibrillary tangles, is also linked to neurovascular dysfunction and blood–brain barrier …
Cerebrovascular phenotypes in mouse models of Alzheimer's disease
JI Szu, A Obenaus - Journal of Cerebral Blood Flow & …, 2021 - journals.sagepub.com
Alzheimer's disease (AD) is a devastating neurological degenerative disorder and is the
most common cause of dementia in the elderly. Clinically, AD manifests with memory and …
most common cause of dementia in the elderly. Clinically, AD manifests with memory and …